2022
DOI: 10.1016/j.isci.2022.103869
|View full text |Cite
|
Sign up to set email alerts
|

Lipid flippase dysfunction as a therapeutic target for endosomal anomalies in Alzheimer’s disease

Help me understand this report
View preprint versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
5
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 9 publications
(9 citation statements)
references
References 49 publications
0
5
0
Order By: Relevance
“…In addition, some members localize to the ER, endosomes and/or lyso somes. Although the involvement of the lipid transporters in the various events, such as endocytic recycling, endocytosis, exocytosis and fission of organelles, has been proposed 29,[243][244][245] , it is not well understood whether the proteins in the scramblase and flippase families have an instructive role in these processes and how exactly they impact these membrane dynamics events. This is because, compared with the proteins in plasma membranes, more difficulties are associated with examining the biological activity of these proteins in specific organelles using a cell-based assay system.…”
Section: Review Articlementioning
confidence: 99%
“…In addition, some members localize to the ER, endosomes and/or lyso somes. Although the involvement of the lipid transporters in the various events, such as endocytic recycling, endocytosis, exocytosis and fission of organelles, has been proposed 29,[243][244][245] , it is not well understood whether the proteins in the scramblase and flippase families have an instructive role in these processes and how exactly they impact these membrane dynamics events. This is because, compared with the proteins in plasma membranes, more difficulties are associated with examining the biological activity of these proteins in specific organelles using a cell-based assay system.…”
Section: Review Articlementioning
confidence: 99%
“…In addition, TMEM30A is essential for insulin maturation and secretion, lymphomagenesis, and skeletal muscle regeneration [ 31 33 ]. This molecule has been identified as a potential therapeutic target for endosomal anomalies in Alzheimer’s disease [ 34 ]. Hearing onset in mice occurs at postnatal days 12–14.…”
Section: Discussionmentioning
confidence: 99%
“…A laboratory in 2018 showed that TMEM30A was a candidate partner for β -carboxyl terminal fragments ( β CTF) of amyloid- β precursor protein (APP), which physically interacted with β CTF in endosomes, impairing vesicle trafficking, resulting in abnormal enlargement of endosomes and impaired APP flow, and leading to the accumulation of APP-CTF, including β CTF [ 41 ]. They further reported in 2022 that the interaction between TMEM30A and β CTF was one of the important pathogenesis of Alzheimer's disease [ 20 ], which inhibited the physiological complex formation and activity of lipid flippase in SH-BACE1 cells, and the BACE1 inhibitor treatment recovered this interaction. In AD model mice, A7 and App NL − G-F/NL − G-F knock-in model mice, they found TMEM30A/ β CTF complex formation and subsequent lipid flippase dysfunction preceded A β deposition.…”
Section: Nervous Systemmentioning
confidence: 99%
“…However, the subcellular localization of the complex is determined by P4-ATPase rather than TMEM30A [ 18 ]. Some researchers indicated that TMEM30A may transport short-chain choline phospholipids into mammalian cells [ 19 ] and regulate the trafficking of amyloid- β precursor protein (APP) in endosomes [ 20 , 21 ]. It is also worth noting that TMEM30A is suggested as the potential receptor for SARS-CoV-2 cell entry, but the mechanism needs further study [ 14 , 22 ].…”
Section: Introductionmentioning
confidence: 99%